These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36819802)

  • 1. Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit.
    Mishra BK; Kapoor A; Gupta A; Sansar B; Singh A; Roy S; Mandal T; Srinivas S; Das S; Mishra A; Mukherjee A; Nanda S; Sambasivaiah K
    Ecancermedicalscience; 2022; 16():1460. PubMed ID: 36819802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
    Nakahara S; Takenaka Y; Ogawa K; Nishiike S; Yamamoto Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Yoshii T; Tomiyama Y; Inohara H
    Int J Clin Oncol; 2016 Dec; 21(6):1030-1037. PubMed ID: 27306220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
    Wang HM; Lin CY; Hsieh CH; Hsu CL; Fan KH; Chang JT; Huang SF; Kang CJ; Liao CT; Ng SH; Yen TC
    J Formos Med Assoc; 2017 Mar; 116(3):185-192. PubMed ID: 27133181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
    Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
    Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer.
    Janinis J; Papadakou M; Panagos G; Panousaki A; Georgoulias V; Hatzidaki D; Lefantzis D; Dokianakis G
    Am J Clin Oncol; 2001 Jun; 24(3):227-31. PubMed ID: 11404490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal.
    Joshi A; Tandon N; Noronha V; Dhumal S; Patil V; Arya S; Juvekar S; Agarwal J; DCruz A; Pai P; Prabhash K
    Indian J Med Paediatr Oncol; 2015; 36(3):172-5. PubMed ID: 26855526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.
    Patil VM; Prabhash K; Noronha V; Joshi A; Muddu V; Dhumal S; Arya S; Juvekar S; Chaturvedi P; Chaukar D; Pai P; Kane S; Patil A; Agarwal JP; Ghosh-Lashkar S; Dcruz A
    Oral Oncol; 2014 Oct; 50(10):1000-4. PubMed ID: 25130412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC).
    Kashyap L; Patil V; Noronha V; Joshi A; Menon N; Jobanputra K; Saha S; Chaturvedi P; Banavali SD; Prabhash K
    Ecancermedicalscience; 2021; 15():1325. PubMed ID: 35211194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
    Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
    Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
    J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?
    Patil VM; Noronha V; Joshi A; Muddu VK; Gulia S; Bhosale B; Arya S; Juvekar S; Chatturvedi P; Chaukar DA; Pai P; D'cruz A; Prabhash K
    Indian J Cancer; 2013; 50(1):1-8. PubMed ID: 23713035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.
    Patil VM; Noronha V; Joshi A; Muddu VK; Dhumal S; Arya S; Juvekar S; Pai P; Chatturvedi P; Devendra AC; Ghosh S; D'cruz A; Kumar P
    Indian J Cancer; 2014; 51(1):20-4. PubMed ID: 24947091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
    Stupp R; Mayer M; Kann R; Weder W; Zouhair A; Betticher DC; Roth AD; Stahel RA; Majno SB; Peters S; Jost L; Furrer M; Thierstein S; Schmid RA; Hsu-Schmitz SF; Mirimanoff RO; Ris HB; Pless M
    Lancet Oncol; 2009 Aug; 10(8):785-93. PubMed ID: 19604722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.
    Shirasu H; Yokota T; Kawakami T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Mori K; Onitsuka T
    Int J Clin Oncol; 2020 Nov; 25(11):1914-1920. PubMed ID: 32648132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.